Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs SUPRIYA LIFESCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA SUPRIYA LIFESCIENCE SANDU PHARMA/
SUPRIYA LIFESCIENCE
 
P/E (TTM) x 52.4 26.6 197.1% View Chart
P/BV x 1.5 4.6 33.1% View Chart
Dividend Yield % 1.2 0.2 806.9%  

Financials

 SANDU PHARMA   SUPRIYA LIFESCIENCE
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
SUPRIYA LIFESCIENCE
Mar-23
SANDU PHARMA/
SUPRIYA LIFESCIENCE
5-Yr Chart
Click to enlarge
High Rs86515 16.7%   
Low Rs50170 29.6%   
Sales per share (Unadj.) Rs67.650.4 134.3%  
Earnings per share (Unadj.) Rs1.611.2 14.1%  
Cash flow per share (Unadj.) Rs2.112.6 16.7%  
Dividends per share (Unadj.) Rs0.750.60 125.0%  
Avg Dividend yield %1.10.2 628.8%  
Book value per share (Unadj.) Rs40.686.9 46.7%  
Shares outstanding (eoy) m9.6680.48 12.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.06.8 14.8%   
Avg P/E ratio x43.330.7 141.0%  
P/CF ratio (eoy) x32.327.1 119.1%  
Price / Book Value ratio x1.73.9 42.5%  
Dividend payout %47.65.4 886.5%   
Avg Mkt Cap Rs m65827,581 2.4%   
No. of employees `000NANA-   
Total wages/salary Rs m111556 20.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6534,054 16.1%  
Other income Rs m3100 3.3%   
Total revenues Rs m6574,154 15.8%   
Gross profit Rs m251,284 1.9%  
Depreciation Rs m5118 4.4%   
Interest Rs m131 2.6%   
Profit before tax Rs m221,235 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7336 2.1%   
Profit after tax Rs m15899 1.7%  
Gross profit margin %3.831.7 12.0%  
Effective tax rate %31.427.2 115.3%   
Net profit margin %2.322.2 10.5%  
BALANCE SHEET DATA
Current assets Rs m2554,649 5.5%   
Current liabilities Rs m139958 14.5%   
Net working cap to sales %17.891.0 19.6%  
Current ratio x1.84.9 37.9%  
Inventory Days Days6524 274.1%  
Debtors Days Days26876 351.1%  
Net fixed assets Rs m2863,554 8.1%   
Share capital Rs m97161 60.0%   
"Free" reserves Rs m2966,834 4.3%   
Net worth Rs m3926,995 5.6%   
Long term debt Rs m00-   
Total assets Rs m5428,203 6.6%  
Interest coverage x28.740.4 71.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.20.5 244.1%   
Return on assets %3.011.3 26.1%  
Return on equity %3.912.8 30.2%  
Return on capital %5.918.1 32.3%  
Exports to sales %088.8 0.0%   
Imports to sales %023.5 0.0%   
Exports (fob) Rs mNA3,598 0.0%   
Imports (cif) Rs mNA953 0.0%   
Fx inflow Rs m03,598 0.0%   
Fx outflow Rs m0953 0.0%   
Net fx Rs m02,645 0.0%   
CASH FLOW
From Operations Rs m2662 0.3%  
From Investments Rs m5-1,331 -0.4%  
From Financial Activity Rs m6-34 -17.2%  
Net Cashflow Rs m13-703 -1.9%  

Share Holding

Indian Promoters % 42.9 68.3 62.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 10.7 0.1%  
FIIs % 0.0 5.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 31.7 180.1%  
Shareholders   10,001 87,980 11.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs SUPRIYA LIFESCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs SUPRIYA LIFESCIENCE Share Price Performance

Period SANDU PHARMA SUPRIYA LIFESCIENCE S&P BSE HEALTHCARE
1-Day -1.25% -3.33% -0.44%
1-Month 4.02% 11.75% -0.19%
1-Year 10.26% 78.99% 53.63%
3-Year CAGR 9.77% 0.60% 14.59%
5-Year CAGR 24.30% 0.36% 19.77%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the SUPRIYA LIFESCIENCE share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of SUPRIYA LIFESCIENCE the stake stands at 68.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of SUPRIYA LIFESCIENCE .

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

SUPRIYA LIFESCIENCE paid Rs 0.6, and its dividend payout ratio stood at 5.4%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of SUPRIYA LIFESCIENCE .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.